Skip to main content
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1983 Jan 1;157(1):353–358. doi: 10.1084/jem.157.1.353

Identification of an I-J+ antigen-presenting cell required for third order suppressor cell activation

PMCID: PMC2186903  PMID: 6217280

Abstract

We have found that an I-J+ I-A- antigen-presenting cell (APC) is required for Ts3 activation in vivo. Together with the I-J restriction previously reported for Ts3 induction (Takaoki, M., M.-S. Sy, A. Tominaga, A. Lowy, M. Tsurifiji, B. Benacerraf, R. Finberg, and M. I. Greene, 1982, J. Exp. Med., 156:1325), it appears that this I-J+ APC is responsible for I-J restriction in the triggering of Ts3. This restriction may be exerted via a pre-Ts3 associative recognition of antigen and I-J encoded determinants, analogous to the T helper recognition of antigen in the context of I-A and I-E determinants.

Full Text

The Full Text of this article is available as a PDF (398.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach B. A., Sherman L., Benacerraf B., Greene M. I. Mechanisms of regulation of cell-mediated immunity. II. Induction and suppression of delayed-type hypersensitivity to azobenzenearsonate-coupled syngeneic cells. J Immunol. 1978 Oct;121(4):1460–1468. [PubMed] [Google Scholar]
  2. Ben-Nun A., Cohen I. R. Spontaneous remission and acquired resistance to autoimmune encephalomyelitis (EAE) are associated with suppression of T cell reactivity: suppressed EAE effector T cells recovered as T cell lines. J Immunol. 1982 Mar;128(3):1450–1457. [PubMed] [Google Scholar]
  3. Britz J. S., Askenase P. W., Ptak W., Steinman R. M., Gershon R. K. Specialized antigen-presenting cells. Splenic dendritic cells and peritoneal-exudate cells induced by mycobacteria activate effector T cells that are resistant to suppression. J Exp Med. 1982 May 1;155(5):1344–1356. doi: 10.1084/jem.155.5.1344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Cullen S. E., Freed J. H., Nathenson S. G. Structural and serological properties of murine Ia alloantigens. Transplant Rev. 1976;30:236–270. doi: 10.1111/j.1600-065x.1976.tb00222.x. [DOI] [PubMed] [Google Scholar]
  5. Germain R. N., Benacerraf B. Helper and suppressor T cell factors. Springer Semin Immunopathol. 1980 May;3(1):93–127. doi: 10.1007/BF00199927. [DOI] [PubMed] [Google Scholar]
  6. Gill H. K., Liew F. Y. Regulation of delayed-type hypersensitivity. III. Effect of cyclophosphamide on the suppressor cells for delayed-type hypersensitivity to sheep erythrocytes in mice. Eur J Immunol. 1978 Mar;8(3):172–176. doi: 10.1002/eji.1830080306. [DOI] [PubMed] [Google Scholar]
  7. Greene M. I., Fujimoto S., Sehon A. H. Regulation of the immune response to tumor antigens. III. Characterization of thymic suppressor factor(s) produced by tumor-bearing hosts. J Immunol. 1977 Aug;119(2):757–764. [PubMed] [Google Scholar]
  8. Nakamura R. M., Tanaka H., Tokunaga T. In vitro induction of suppressor T-cells in delayed-type hypersensitivity to BCG and an essential role of I-J positive accessory cells. Immunol Lett. 1982 Jun;4(6):295–299. doi: 10.1016/0165-2478(82)90055-4. [DOI] [PubMed] [Google Scholar]
  9. Rolink A. G., Radaszkiewicz T., Pals S. T., van der Meer W. G., Gleichmann E. Allosuppressor and allohelper T cells in acute and chronic graft-vs-host disease. I. Alloreactive suppressor cells rather than killer T cells appear to be the decisive effector cells in lethal graft-vs.-host disease. J Exp Med. 1982 May 1;155(5):1501–1522. doi: 10.1084/jem.155.5.1501. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Scher I. The CBA/N mouse strain: an experimental model illustrating the influence of the X-chromosome on immunity. Adv Immunol. 1982;33:1–71. doi: 10.1016/s0065-2776(08)60834-2. [DOI] [PubMed] [Google Scholar]
  11. Schwartz R. H., Yano A., Stimpfling J. H., Paul W. E. Gene complementation in the T-lymphocyte proliferative response to poly (Glu55Lys36Phe9)n. A demonstration that both immune response gene products must be expressed in the same antigen-presenting cell. J Exp Med. 1979 Jan 1;149(1):40–57. doi: 10.1084/jem.149.1.40. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sherman L. A., Burakoff S. J., Benacerraf B. The induction of cytolytic T lymphocytes with specificity for p-azophenylarsonate coupled syngeneic cells. J Immunol. 1978 Oct;121(4):1432–1436. [PubMed] [Google Scholar]
  13. Sy M. S., Brown A. R., Benacerraf B., Greene M. I. Antigen- and receptor-driven regulatory mechanisms. III. Induction of delayed type hypersensitivity to azobenzenearsonate with anti-cross-reactive idiotypic antibodies. J Exp Med. 1980 Apr 1;151(4):896–909. doi: 10.1084/jem.151.4.896. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Sy M. S., Dietz M. H., Germain R. N., Benacerraf B., Greene M. I. Antigen- and receptor-driven regulatory mechanisms. IV. Idiotype-bearing I-J+ suppressor T cell factors induce second-order suppressor T cells which express anti-idiotypic receptors. J Exp Med. 1980 May 1;151(5):1183–1195. doi: 10.1084/jem.151.5.1183. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Takaoki M., Sy M. S., Tominaga A., Lowy A., Tsurufuji M., Finberg R., Benacerraf B., Greene M. I. I-J-restricted interactions in the generation of azobenzenearsonate-specific suppressor T cells. J Exp Med. 1982 Nov 1;156(5):1325–1334. doi: 10.1084/jem.156.5.1325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Takaoki M., Sy M. S., Tominaga A., Lowy A., Tsurufuji M., Finberg R., Benacerraf B., Greene M. I. I-J-restricted interactions in the generation of azobenzenearsonate-specific suppressor T cells. J Exp Med. 1982 Nov 1;156(5):1325–1334. doi: 10.1084/jem.156.5.1325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Zembala M., Asherson G. L., Colizzi V. Hapten-specific T suppressor factor recognizes both hapten and I-J region products on haptenized spleen cells. Nature. 1982 Jun 3;297(5865):411–413. doi: 10.1038/297411a0. [DOI] [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES